The global stockpile of cholera vaccines the World Health Organization helps manage is “currently empty or extremely low”, a WHO official said on Friday amid a resurgence of the disease around the world.

The Biden administration said Thursday it had removed Wuxi Biologics, a company that makes ingredients for AstraZeneca’s COVID-19 vaccine, and about two dozen other Chinese entities from a so-called unverified list that forces U.S. suppliers to perform greater due diligence before shipping to them.

For the fifteenth year, MedAdNews has chosen new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.

To address its outsized environmental footprint, pharma is stepping up its initiatives to meet or exceed net zero standards for carbon emissions.

The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to “persist” until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.

The partnership with non-profit IVI, headquartered in South Korea, aims to boost output and reduce vaccine shortages amid a spate of global outbreaks that spurred the World Health Organization to temporarily change its dosage regime.

The company cited Gavi’s failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.

The Southeast Asian country temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.

Moderna Inc cut its annual sales forecast for its COVID-19 vaccine, citing short-term supply constraints that would push some deliveries to next year, sending its shares down nearly 11% before the bell.

Indegene will leverage its healthcare domain expertise and experience in operating digital centers of excellence to help streamline AstraZeneca’s global content supply chain and orchestrate personalized customer journeys in an agile, global engagement model.